Genetic testing in asymptomatic minors: Background considerations towards ESHG Recommendations

European Journal of Human Genetics

Volumn 17, Issue 6, 2009, Pages 711-719

  Borry, Pascal ^a   Evers Kiebooms, Gerry ^b   Cornel, Martina C ^c   Clarke, Angus ^d   Dierickx, Kris ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CHILD HEALTH CARE; CLINICAL GENETICS; GENETIC ANALYSIS; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HETEROZYGOTE DETECTION; HUMAN; JUVENILE; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; MEDICAL ETHICS; ONSET AGE; PATIENT PARTICIPATION; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CHILD; ETHICS, MEDICAL; GENETIC COUNSELING; GENETIC SCREENING; GENETICS, MEDICAL; GREAT BRITAIN; HEALTH PLANNING GUIDELINES; HEALTH POLICY; HUMANS; MINORS; SOCIETIES, MEDICAL;

EID: 67349164838     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2009.25     Document Type: Article

References (99)

1. Borry P, Stultiens L, Nys H, Cassiman JJ, Dierickx K: Presymptomatic and predictive genetic testing in minors: A systematic review of guidelines and position papers. Clin Genet 2006; 70: 374-381.
2. Borry P, Schotsmans P, Fryns JP, Dierickx K: Carrier testing in minors: a systematic review of guidelines and positions statements. Eur J Hum Genet 2006; 14: 133-138.
3. Hayhurst R, Cassiman JJ: EuroGentest standing up to scrutiny - first year demonstrates good progress harmonizing community approaches. J Appl Genet 2006; 47: 5-7.
4. Cassiman JJ: EuroGentest - a European Network of Excellence aimed at harmonizing genetic testing services. Eur J Hum Genet 2005; 13 1103-1105.
5. Borry P, Fryns JP, Dierickx K: Predictive genetic testing in children. A clinical-ethical analysis; in de Bouvet A, Boitte P, Aiguier G (eds): Questions éthique en médicine predictive. Montrouge, Editions John Libbey Eurotext, 2006, pp 89-98.
6. Borry P, Dierickx K: Carrier testing for congenital adenal hyperplasia: ethical issues. Cares 2007; 6: 16-18.
7. Borry P, Nys H, Dierickx K: Ethics watch - carrier testing in minors: conflicting views. Nat Rev Genet 2007; 8: 828.
8. Stultiens L, Goffin T, Borry P, Dierickx K, Nys H: Minors and informed consent: A comparative approach. Eur J Health Law 2007; 14: 21-46.
9. Nys H, Stultiens L, Borry P, Goffin T, Dierickx K: Patient rights in EU member states after the ratification of the convention on human rights and biomedicine. Health Policy 2007; 83: 223-235.
10. Borry P, Stultiens L, Nys H, Dierickx K: Attitudes towards predictive genetic testing in minors for familial breast cancer: A systematic review. Crit Rev Oncol Hematol 2007; 64: 173-181.
11. Borry P, Schotsmans P, Fryns JP, Dierickx K: Attitudes of minors, parents and health professionals towards carrier testing in minors: A systematic review. Genet Couns 2005; 16: 341-352.
12. Borry P, Goffin T, Nys H, Dierickx K: Attitudes regarding carrier testing in incompetent children. A survey of European clinical geneticists. Eur J Hum Genet 2007; 15: 1211-1217.
13. Borry P: Minors and informed consent in carrier testing. A survey of European clinical geneticists. J Med Ethics 2008; 34: 370-374.
14. Borry P, Goffin T, Nys H, Dierickx K: Attitudes regarding predictive genetic testing in minors. A survey of European clinical geneticists. Am J Med Genet C Semin Med Genet 2008; 148C: 78-83.
15. Andorno R: The OvAedo Convention: a European framework at the intersection of human rights and health law. J Int Biotechnol Law 2005; 2: 133-143.
16. Buchanan AE, Brock DW: Deciding for Others. Cambridge: University Press, 1989.
17. Dawson A: The determination of the best interests in relation to childhood immunisation. Bioethics 2005; 19: 72-89.
18. Downie RS, Randall F: Parenting and the best interests of minors. J Med Philos 1997; 22: 219-231.
19. Ross LF: Health care decision making by children. Is it in their best interest? Hastings Cent Rep 1997; 27: 41-45.
20. Spence K: The best interest principle as a standard for decision making in the care of neonates. J Adv Nurs 2000; 31: 1286-1292.
21. Trau JM, McCartney JJ: In the best interest of the patient. Applying this standard to healthcare decision making must be done in a community context. Health Prog 1993; 74: 50-56.
22. Charter of Fundamental Rights of the European Union, http://www.europarl.europa.eu/charter/pdf/text_en.pdf, 2000.
23. Universal Declaration on the Human Genome and Human Rights; Unesco, http://portal.unesco.org/shs/en/ev.php-URL_ID=1881&URL_DO= DO_TOPIC&URL_SECTION=201.html, 1997.
24. Kopelman LM: The best-interests standard as threshold, ideal, and standard of reasonableness. J Med Philos 1997; 22: 271-289.
25. Kopelman LM: ChildUen and bioethics: uses and abuses of the best-interests standard. J Med Philos 1997; 22: 213-217.
26. United Nations. Convention on the Rights of the Child, http://www.unhchr.ch/html/menu3/b/k2crc.htm, 1989.
27. Alderson P, Montgomery J: Health Care Choices: Making Decisions with Children. London: Institute for Public Policy Research, 1996.
28. Royal College of Psychiatrists Report: Appendix 2 -Children's Level of Understanding of Medical Decisions; Guidance for Researchers and for Ethics Committees on Psychiatric Research Involving Human Participants London: The Royal College of Psychiatrists, 2001.
29. British Medical Association: Consent, Rights and Choices in Health Care for Children and Young People. London: BMJ Books, 2001.
30. Informed consent, parental permission, and assent in pediatric practice: Committee on Bioethics, American Academy of Pediatrics. Pediatrics 1995; 95: 314-317.
31. Council of Europe. Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the application of Biology and Medicine: Convention on Human Rights and Biomedicine. Oviedo, Council of Europe, 1997.
32. Clarke A, Richards M, Kerzin-Storrar L et al: Genetic professionals; reports of nondisclosure of genetic risk information within families. Eur J Hum Genet 2005; 13: 556-562.
33. Loud JT, Weissman NE, Peters JA et al: Deliberate deceit of family members: A challenge to providers of clinical genetics services. J Clin Oncol 2006; 24: 1643-1646.
34. Fanos JH: Developmental tasks of childhood aId adolescence: implications for genetic testing. Am J Med Genet 1997; 71 (1): 22-28.
35. Denayer L, Welkenhuysen M, Evers-Kiebooms G, Cassiman JJ, Van den BH: Risk perception after CF carrier testing and impact of the test result on reproductive decision making. Am J Med Genet 1997; 69: 422-428.
36. Fanos JH, Johnson JP: Perception of carrier status by cystic fibrosis siblings. Am J Hum Genet 1995; 57: 431-438.
37. Denayer L, De Boeck K, Evers-Kiebooms G, Van den BH: The transfer of information about genetic transmission to brothers and sisters of parents with a CF-child. Birth Defects Orig Artic Ser 1992; 28 149-158.
38. Axworthy D, Brock DJ, Bobrow M, Marteau TM: Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group. Lancet 1996; 347: 1443-1446.
39. Bekker H, Modell M, Denniss G et al: Uptake of cystic fibrosis testing in primary care: Supply push or demand pull? BMJ 1993; 306: 1584-1586.
40. Bekker H, Denniss G, Modell M, Bobrow M, Martea-T: The impact of population based screening for carriers of cystic fibrosis. J Med Genet 1994; 31: 364-368.
41. Watson EK, Mayall E, Chapple J et al: Screening for carriers of cystic fibrosis through primary health care services. BMJ 1991; 303: 504-507.
42. Mennie ME, Gilfillan A, Compton M et al: Prenatal screening for cystic fibrosis. Lancet 1992; 340: 214-216.
43. Callanan NP, Cheuvront BJ, Sorenson JR: CF carrier testing in a high risk population: Anxiety, risk perceptions, and reproductive plans of carrier by 'non-carrier' couples. Genet Med 1999; 1: 323-327.
44. Marteau TM, Michie S, Miedzybrodzka ZH, Allanson A: Incorrect recall of residual risk three years after carrier screening for cystic fibrosis: A comparison of two-step and couple screening. Am J Obstet Gynecol 1999; 181: 165-169.
45. Fanos JH, Mackintosh MA: NTver again joy without sorrow: the effect on parents of a child with ataxia-telangiectasia. Am J Med Genet 1999; 87: 413-419.
46. Fanos JH, Nickerson BG: Long-term effects of sibling death during adolescence. J Adolesc Res 1991; 6: 70-82.
47. Mischler EH, Wilfond BS, Fost N et al: Cystic fibrosis newborn screening: Impact on reproductive behavior and implications for genetic counseling. Pediatrics 1998; 102: 44-52.
48. Ciske DJ, Haavisto A, Laxova A, Rock LZ, Farrell PM: Genetic counseling and neonatal screening for cystic fibrosis: An assessment of the communication process. Pediatrics 2001; 107: 699-705.
49. Forrest K, Simpson SA, Wilson BJ et al: To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 2003; 64: 317-326.
50. Varekamp I, Suurmeijer TP, Brocker-Vriends AH et al: Carrier testing and prenatal diagnosis for hemophilia: Experiences and attitudes of 549 potential and obligate carriers. Am J Med Genet 1990; 37 147-154.
51. Varekamp I, Suurmeijer T, Brocker-Vriends A, Rosendaal FR: Hemophilia and the use of genetic counseling and carrier testing within family networks. Birth Defects Orig Artic Ser 1992; 28: 139-148.
52. Varekamp I, Suurmeijer TP, Rosendaal FR, Brocker-Vriends AH: The use of preventive health care services: Carrier testing for the genetic disorder haemophilia. Soc Sci Med 1993; 37: 639-648.
53. Sorenson JR, Jennings-Grant T, Newman J: Communication about carrier testing within hemophilia A families. Am J Med Genet 2003; 119C 3-10.
54. Fanos JH, Johnson JP: Barriers to carrier testing for adult cystic fibrosis sibs: The importance of not knowing. Am J Med Genet 1995; 59: 85-91.
55. Duster T: The social consequences of genetic disclosure; in: Carson RA, Rothstein MA (eds): Behavioral Genetics. The Clash of Culture and Biology. London: John Hopkins University Press, 1999, pp 172-188.
56. Sharpe NF: The duBy to recontact: benefit and harm. Am J Hum Genet 1999; 65: 1201-1204.
57. Borry P, Dierickx K: What are the limits of the duty of care? The case of clinical genetics. Per Med 2008; 5: 101-104.
58. Biesecker BB: Future directions in Penetic counseling: practical and ethical considerations. Kennedy Inst Ethics J 1998; 8: 145-160.
59. Elwyn G, Gray J, Clarke A: Shared decision making and non-directiveness in genetic counselling. J Med Genet 2000; 37: 135-138.
60. Oduncu FS: The role of non-directiveness in genetic counseling. Med Health Care Philos 2002; 5: 53-63.
61. Metcalfe A: Consultation on testing in minors recommendations, personal communication, 2008.
62. Harper P, Clarke A: Genetics, Society and Clinical Practice. Oxford: Bios, 1997.
63. Codori AM, Zawacki KL, Petersen GM et al: Genetic testing for hereditary colorectal cancer in children: Long-term psychological effects. Am J Med Genet A 2003; 116A: 117-128.
64. Allan D: Ethical boundaries in genetic testing. CMAJ 1996; 154 241-244.
65. Godard B, Kaariainen H, Kristofferson U et al: Provision of Genetic Services in Europe - current practices and issues. Eur J Hum Genet 2003; 11(Suppl 2): S13-S48.
66. European Society of Human Genetics: Provision of Genetic services in Europe - current practices and issues. Eur J Hum Genet 2003; 11 (Suppl 2): S2-S4.
67. Clarke A: The Genetic Testing of Children. Oxford: Bios, 1998.
68. Clarke A, Flinter F: The geAetic testing of children: a clinical perspective, in: Marteau T, Richards M (eds): The Troubled Helix: Social and Psychological Implications of the New Human Genetics. Cambridge: Cambridge University Press, 1996, pp 164-176.
69. Clarke A: The genetic testing of children. J Med Genet 1995; 32 492.
70. German Society of Human Genetics: Statement on genetic diagnosis in children and adolescents, http://www.gfhev.de/en/gfh/, 1995.
71. Danish Council of Ethics: Genetic Investigation of Healthy Subjects - Report on Presymptomatic Gene Diagnosis. http://www.etiskraad.dk/ sw293.asp, 2001.
72. Borry P, Goffin T, Nys H, Dierickx K: Predictive genetic testing in minors for adult-onset genetic diseases. Mt Sinai J Med 2008; 75: 287-296.
73. Rhodes R: Why test children for adult-onset genetic diseases? Mt Sinai J Med 2006; 73: 609-616.
74. Hayes CV: Genetic testing for Huntington's disease-a family issue. N Engl J Med 1992; 327: 1449 -1451.
75. Grosfeld FJ, Beemer FA, Lips CJ, Hendriks KS, ten Kroode HF: Parents' responses to disclosure of genetic test results of their children. Am J Med Genet 2000; 94: 316-323.
76. Quaid KA, Morris M: Reluctance to unTergo predictive testing: the case of Huntington disease. Am J Med Genet 1993; 45: 41-45.
77. Malpas PJ: Why tell asymptomatic children of the risk of an adult-onset disease in the family but not test them for it? J Med Ethics 2006; 32: 639-642.
78. Rhodes R: Why test children for adifit-onset genetic diseases? Mt Sinai J Med 2006; 73: 609-616.
79. Skirton H: Telling the children; in: Clarke A (eds): The Genetic Testing of Children. Oxford: Bios, 1998, pp 103-111.
80. Campbell E, Ross LF: Parental attitudes and beliefs regarding the genetic testing of children. Community Genet 2005; 8: 94-102.
81. Hamann HA, Croyle RT, Venne VL, Baty BJ, Smith KR, Botkin JR: Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation. Am J Med Genet 2000; 92 25-32.
82. Benkendorf JL, Reutenauer JE, Hughes CA et al: Patients' attitudes about autonomy and confidentiality in genetic testing for breastovarian cancer susceptibility. Am J Med Genet 1997; 73: 296-303.
83. Evers-Kiebooms G: Predictief testen van minderjarigen voor aandoeningen die later in het leven tot uiting komen: Psychologische aspecten en multidisciplinaire aanpak. Tijdschrift voor geneeskunde 2006; 62: 463-471.
84. Swiss Academy of Medical Sciences: Genetic investigations in humans, http://www.samw.ch/, 1993.
85. Human Genetics Socidy of Australasia: DNA presymptomatic and predictive testing for genetic disorders, http://www.hgsa.com.au/policy/ dnaptgd.html, 2002.
86. The American Society of Human Genetics Board of Directors and The American College of Medical Genetics Board of Directors: Points to consider: Ethical, legal, and psychological impications of genetic testing in children and adolescents. Am J Hum Genet 1995; 57 1233-1241.
87. Task Force on Genetic Testing: Promoting safe and effective genetic testing in the United States, http://www.genome.gov/10001733, 1997.
88. Canadian College of Medical Geneticists: Genetic testing of children, http://ccmg.medical.org/, 2000.
89. Bioethics Committee Canadian Paediatric Society: Guidelines for genetic testing of healthy children. Paediatr Child Health 2003; 8: 42-45.
90. Committee on Bioethics: Ethical issues with genetic testing in pediatrics. Pediatrics 2001; 107: 1451.
91. Dalby S: GIG response to the UK Clinical Genetics Society report 'The genetic testing of children'. J Med Genet 1995; 32: 490-491.
92. Clarke A: The genetic testing of children. Working Party of the Clinical Genetics Society (UK). J Med Genet 1994; 31: 785-797.
93. American Medical Association: Testing children for genetic status, http://www.ama-assn.org/, 1995.
94. Barnes C: Carrier testinC in childhood: conflict or compromise. http://www.medacid.org/eshg/abstracts/eshgplenary.htm, 2002.
95. McConkie-Rosell A, Spiridigliozzi GA, Rounds K et al: Parental attitudes regarding carrier testing in children at risk for fragile X syndrome. Am J Med Genet 1999; 82: 206-211.
96. James CA, Holtzman NA, Hadley DW: Perceptions of reproductive risk and carrier testing among adolescent sisters of males with chronic granulomatous disease. Am J Med Genet 2003; 119C: 60-69.
97. Green NS, DolCn SM, Murray TH: Newborn screening: complexities in universal genetic testing. Am J Public Health 2006; 96: 1955-1959.
98. UK Newborn Screening Programme Centre: Newborn blood spot screening in the UK Policies and Standards. http://www.newbornbloodspot.screening.nhs.uk/download/ policies_standards.pdf, 2005.
99. Health Resources and Services Administration: Newborn Screening: Toward a Uniform Screening Panel and System, ftp://ftp.hrsa.gov/mchb/genetics/ screeningdraftforcomment.pdf, 2005.